Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
investment
Biotech
Series B round of $125M will fund Diagonal's move into clinic
With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class rare disease drug, DIAG723.
Kevin Dunleavy
Jan 8, 2026 6:30am
Pharma's 'urgent need for reinvention': PwC's call to action
Jan 8, 2026 6:00am
Fierce Pharma
3 biopharma CEOs explain why they are 'authentically optimistic'
Jan 6, 2026 11:54am
FDA's 1-trial approval plan would boost R&D spend: Jefferies
Dec 5, 2025 11:00am
TCG Crossover hauls in $1.3B for 3rd investment fund
Oct 6, 2025 11:14am
Sanofi juices up venture arm with $625M infusion
Sep 24, 2025 1:00am